Dupilumab Efficacy in Patients with Type 2 Asthma with and without Elevated Blood Neutrophils
Introduction. Elevated neutrophil counts in blood, sputum, or lung have been associated with poor clinical outcomes and more severe disease in patients with type 2 asthma. In the phase 3 LIBERTY ASTHMA QUEST (NCT02414854), add-on dupilumab 200 and 300 mg every 2 weeks compared with matched placebo s...
Saved in:
| Main Authors: | Eugene R. Bleecker, Reynold A. Panettieri, Njira L. Lugogo, Jonathan Corren, Nadia Daizadeh, Juby A. Jacob-Nara, Yamo Deniz, Paul J. Rowe, Angela Khodzhayev, Xavier Soler, Thomas J. Ferro, Christopher N. Hansen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-01-01
|
| Series: | Journal of Immunology Research |
| Online Access: | http://dx.doi.org/10.1155/2023/9943584 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Long-term dupilumab efficacy in type 2 asthma regardless of baseline characteristics
by: Michael E. Wechsler, et al.
Published: (2024-12-01) -
Dupilumab efficacy in patients with type 2 asthma and early Feno level reductions
by: Ian D. Pavord, MD, et al.
Published: (2025-08-01) -
Correction to: G12/13 signaling in asthma
by: Elizabeth L. McDuffie, et al.
Published: (2024-10-01) -
Achievement of Control of Severe Bronchial Asthma When Using Dupilumab
by: O. V. Kazmerchuk, et al.
Published: (2024-11-01) -
Effective use of dupilumab for eosinophilic gastritis concomitant with severe asthma
by: Tomohito Takeshige, et al.
Published: (2024-12-01)